Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRemoved the keyword 'Interstitial lung disease 2' from the page metadata/keywords.SummaryDifference0.1%

- Check16 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check37 days agoChange DetectedPulmonary fibrosis was added to the Keywords/MeSH terms to better reflect the studied condition and improve indexing.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated to v3.4.2 and the earlier v3.4.1 funding/operational notice was removed. No study-related content, eligibility criteria, or results were changed.SummaryDifference0.5%

- Check58 days agoChange DetectedAdded a public notice about a lapse in government funding and updated the page revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.